Clinical Trial Update: A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update: A phase 1/2 study evaluating RC278 for safety and efficacy in patients with solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• RC278

Snippet

Sponsor: RemeGen Co., Ltd. | Conditions: Solid Tumors | Phase 1, Phase 2 | Status: RECRUITING